Home » Topics » BioWorld Science

BioWorld Science
RSS

Gilead presents first-in-human data for GS-9688 at The Liver Meeting

Nov. 12, 2018

Activation of the cellular stress response protects cells from neurotoxicity in Parkinson's disease

Nov. 12, 2018

Genetic determinants of cortical thickness in Alzheimer's disease revealed

Nov. 12, 2018

SCaV11 immunogen selectively elicits CD8+ T cells but not CD4+ T cells targeting viral antigens

Nov. 12, 2018

Combination of IDLV-SIV-Gag and IDLV-PGT121 results in prolonged virus control in vivo

Nov. 12, 2018

Mutations in DKGE cause C3 glomerulopathy

Nov. 12, 2018

Purinergic receptor mutations cause congenital neurogenic bladder

Nov. 12, 2018

Adjunctive LHW-090 safely lowers blood pressure in patients with resistant hypertension

Nov. 12, 2018

Phase I data on BBT-401 pave way for phase II ulcerative colitis study

Nov. 12, 2018

Retrotope begins phase II/III study of RT-001 in infantile neuroaxonal dystrophy

Nov. 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...